Health Condition 1: null- ASA grade I and II who are posted for elective laparoscopic cholecystectomy
Conditions
Interventions
Intervention1: Levetiracetam: Levetiracetam is a novel antiepileptic drug with broad spectrum anticonvulsant property and unusually high safety margin.Patients in this group will receive 500 mg lev
Sponsors
Nazareth Hospital
Eligibility
Inclusion criteria
Inclusion criteria: ASA I and II, scheduled for elective laparoscopic cholecystectomy
Exclusion criteria
Exclusion criteria: 1. Patients with known sensitivity to Levetiracetam or Iron tablet. 2. Patients who do not give consent to be enrolled in the study. 3. Patient who has seizure disorder 4. history of chronic pain 5. pregnant or breast feeding females 6. Uncontrolled medical disease ( diabetes mellitus and hypertension) 7. impaired kidney or liver function 8. body mass index (BMI) 35 kg/m2 9. unable to understand pain score
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of post operative pain in terms of visual analogue score (0 to 100)Timepoint: within 24 hours after completion of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Sedation ( Ramsay sedation score) 2. Requirement of rescue analgesiaTimepoint: within 24 hours after completion of surgery | — |
Countries
India
Contacts
Public ContactSaurabh Kumar Das
Nazareth Hospital
Outcome results
None listed